Patent: 9,738,905

Try a free trial See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,738,905

Title:	Vector for expressing NC protein of HIV and method for producing NC protein using the same
Abstract:	The present invention relates to a vector for expressing an NC protein of HIV and a method for producing an NC protein using the same. More particularly, the present invention relates to a vector for expressing an NC protein of HIV, in which an intron sequence and an mRNA stability element in the downstream of NC gene are sequentially linked, and a method for producing an NC protein using the same. The vector for expressing an NC protein of HIV of the present invention, in which an intron sequence and an mRNA stability element in the downstream of NC gene are sequentially linked, can express a wild type NC protein in animal cells, and has an effect of improving the expression efficiency, as compared to a known art.
Inventor(s):	You; Ji Chang (Seoul, KR)
Assignee:	You; Ji Chang (Seoul, KR) AVIXGEN INC. (Seoul, KR)
Application Number:	12/520,147
Patent Claims:	see list of patent claims

Details for Patent 9,738,905

Glossary

Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Patent Expiration	Status	Orphan	Source
Schering	INTRON A	interferon alfa-2b	VIAL	103132	003	1986-06-04	➤ Sign Up	You; Ji Chang (Seoul, KR) AVIXGEN INC. (Seoul, KR)	➤ Sign Up	RX		search
Schering	INTRON A	interferon alfa-2b	VIAL	103132	002	1986-06-04	➤ Sign Up	You; Ji Chang (Seoul, KR) AVIXGEN INC. (Seoul, KR)	➤ Sign Up	RX		search
Schering	INTRON A	interferon alfa-2b	VIAL	103132	001	1986-06-04	➤ Sign Up	You; Ji Chang (Seoul, KR) AVIXGEN INC. (Seoul, KR)	➤ Sign Up	RX		search
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Patent Expiration	Status	Orphan	Source

International Patent Family for US Patent 9,738,905

Subscribe to access the full database, or try a Free Trial
Country	Patent Number	Publication Date
World Intellectual Property Organization (WIPO)	2008075911	Jun 26, 2008
United States of America	2010047865	Feb 25, 2010
South Korea	101158755	Jun 22, 2012
South Korea	101158756	Jun 22, 2012
South Korea	20080057750	Jun 25, 2008
South Korea	20080057751	Jun 25, 2008
Country	Patent Number	Publication Date

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.